As is typically the case, medtech financing levels in the month following a month at or near record high levels is a big drop (even below the monthly “average”). Such was the case in September 2012, when medtech financings reached a meager $270 million following the breakout month of August with its better than $600 million in medtech fundings.
For September, the key fundings were:
- $36 million for Tandem Diabetes Care, Inc.
- $33 million for Torax Medical, Inc.
- $28 million for IlluminOSS Medical, Inc.
- $20 million for Mainstay Medical Ltd.
The complete list of fundngs in medtech for September is provided at link.